Valor2022202320242025Total de pasivos3.92 B3.56 B3.44 B3.85 BCapital total-67.6 M-30 M-36.2 M-15.4 MTotal de pasivos y patrimonio neto8.86 B8.56 B6.42 B5.77 BDeuda total208.7 M140.2 M2.69 B2.88 BDeuda neta-136.3 M-27.1 M2.59 B2.71 B
QuidelOrtho Corporation
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.